NIH Common Fund Initiatives
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional) (RFA-RM-19-007)
The NIH Transformative Research Awards complements NIH’s traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Deadline for application – September 20, 2019, by 5:00 PM local time of applicant organization.
This program expires on September 21, 2019.
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-19-005)
The NIH Pioneer Award initiative complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on a broad area of biomedical or behavioral research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere.
Deadlines for application – September 9, 2019 by 5:00 PM local time of applicant organization.
This programs expires on September 10, 2019.
NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) (RFA-RM-19-006)
The NIH Director’s New Innovator (DP2) Award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The New Innovator Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Director’s New Innovator Award initiative is a component of the High Risk - High Reward Research Program of the NIH Common Fund.
Deadlines for application – August 26, 2019 by 5:00 PM local time of applicant organization.
This program expires on August 27, 2019.
NIH Directors Early Independence Award (DP5 Clinical Trial Optional) (RFA-RM-19-013)
The NIH Director’s Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.
Deadline for application – September 13, 2019, by 5:00 PM local time of applicant organization.
This program expires on September 14, 2019.
Dr. Hua-Chuan Sim, email@example.com.